DSPE-PEG2000-BR2
DSPE-PEG2000-BR2 is a PEG compound which composed of DSPE and a BR2. BR2 is a targeting peptide composed of 17 amino acids with the sequence RAGLQFPVGRLLRRLLR. It has the ability to assist cells to penetrate the membrane and can specifically target certain cells or tissues[1].
Product Specifications
UNSPSC
12352200
Target
Liposome
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[Mal-Cys-RAGLQFPVGRLLRRLLR]C(CCOCCOC(NCCOP(OC[C@](COC(CCCCCCCCCCCCCCCCC)=O)([H])OC(CCCCCCCCCCCCCCCCC)=O)(O)=O)=O)=O.[n]
Molecular Weight
2000 (Average)
References & Citations
[1]de Sousa Cabral LG, et al. The BR2 peptide associated with 2-aminoethyl dihydrogen phosphate is a formulation with antiproliferative potential for a triple-negative breast cancer model. Biomed Pharmacother. 2022 Sep;153:113398.
Shipping Conditions
Room temperature
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![3-[[p- (2-Pyridylsulfamoyl) phenyl]azo]salicylic acid](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
IP27943-01 10 mg
3-[[p- (2-Pyridylsulfamoyl) phenyl]azo]salicylic acid
Sign In for Pricing
View Details IP27943-02 25 mg
3-[[p- (2-Pyridylsulfamoyl) phenyl]azo]salicylic acid
Sign In for Pricing
View Details IP27943-03 50 mg
3-[[p- (2-Pyridylsulfamoyl) phenyl]azo]salicylic acid
Sign In for Pricing
View Details IP27943-04 100 mg
3-[[p- (2-Pyridylsulfamoyl) phenyl]azo]salicylic acid
Sign In for Pricing
View Details 
GTR15337698 1 Vial
Lentiviral human LPXN shRNA (UAS) - Lentiviral human LPXN shRNA (UAS, iRFP) (100)
Sign In for Pricing
View Details